Skip to main content
PMC home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;94(7):644–649. doi: 10.1111/j.1349-7006.2003.tb01497.x

Screening of stress enhancer based on analysis of gene expression profiles: Enhancement of hyperthermia‐induced tumor necrosis by an MMP‐3 inhibitor

Naoki Kato 1, Takeshi Kobayashi 1, Hiroyuki Honda 1,✉
PMCID: PMC11160297  PMID: 12841876

Abstract

To improve the therapeutic benefit of hyperthermia, we examined changes of global gene expression after heat shock using DNA microarrays consisting of 12 814 clones. HeLa cells were treated for 1 h at 44°C and RNA was extracted from the cells 0, 3, 6, and 12 h after heat shock. The 664 genes that were up or down‐regulated after heat shock were classified into 7 clusters using fuzzy adaptive resonance theory (fuzzy ART). There were 41 genes in two clusters that were induced in the early phase after heat shock. In addition to shock response genes, such as hsp70 and hsp40, the stress response genes c‐jun, c‐fos and egr‐1 were expressed in the early phase after heat shock. We also found that expression of matrix metalloproteinase 3 (MMP‐3) was enhanced during the early response. We therefore investigated the role of MMP‐3 in the heat shock response by examining HeLa cell survival after heat treatment in the presence and absence of an MMP‐3 inhibitor, N‐isobutyl‐N‐(4‐methoxyphenyl‐sulfonyl)glycylhydroxamic acid (NNGH) or N‐hydroxy‐2(R)‐[[4‐methoxysulfonyl] (3‐picolyl)amino]‐3‐methylbutaneamide hydro‐chloride (MMI270). The number of surviving cells 3 days after heat treatment significantly decreased, reaching 3.5% for NNGH and 0.2% for MMI270. These results indicate that the MMP‐3 inhibitors enhanced heat shock‐induced cell death and behaved as stress enhancers in cancer cells. This valuable conclusion was reached as a direct result of the gene expression profiling that was performed in these studies.

References

  • 1. Cavaliere R, Ciocatto EC, Giovanella BC, Heidelburger C, Jonson RO, Margottini M, Mondovi B, Moricca BG, Rossi‐Fanelli A. Selective heat sensitivity of cancer cells. Cancer 1967; 20: 1351–81. [DOI] [PubMed] [Google Scholar]
  • 2. Perez CA, Kopecky W, Rao DV, Baglan R, Mann J. Local microwave hyperthermia and irradiation in cancer therapy: preliminary observations and directions for future clinical trials. Int J Radiat Oncol Biol Phys 1981; 7: 765–72. [DOI] [PubMed] [Google Scholar]
  • 3. Gerner EW, Schneider MJ. Induced thermal resistance in HeLa cells. Nature 1975; 256: 500–2. [DOI] [PubMed] [Google Scholar]
  • 4. Riabowl KT, Mizzen LA, Welch WJ. Heat shock is lethal to fibroblasts microinjected with antibodies against hsp70. Science 1988; 242: 433–6. [DOI] [PubMed] [Google Scholar]
  • 5. Beck SC, Maio A. Stabilization of protein in thermotolerant cells during heat shock. Association of heat shock protein‐72 with ribosomal subunits of poly‐somes. J Biol Chem 1994; 269: 21803–11. [PubMed] [Google Scholar]
  • 6. Landry J, Chretien P, Lambert H, Hickey E, Weber LA. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 1989; 109: 7–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Mehlen P, Preville X, Chareyron P, Briolay J, Klemenz R, Arrigo AP. Constitutive expression of human hsp27, Drosophila hsp27, or human alpha B‐crystallin confers resistance to TNF‐ and oxidative stress‐induced cytotoxicity in stably transfected murine L929 fibroblasts. J Immunol 1995; 154: 363–74. [PubMed] [Google Scholar]
  • 8. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res 1998; 89: 463–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res 1997; 88: 630–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 1998; 89: 775–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Srivastava PK, MSeAnoret A, Basu S, Binder R, Quade K. Heat shock proteins come of age: primitive functions acquired new roles in an adaptive world. Immunity 1998; 8: 657–65. [DOI] [PubMed] [Google Scholar]
  • 12. Ménoret A, Chandawarkar R. Heat‐shock protein‐based anticancer immuno‐therapy: an idea whose time has come. Semin Immunol 1998; 25: 654–60. [PubMed] [Google Scholar]
  • 13. Castelli C, Ciupitu AM, Rini F, Rivoltini L, Mazzocchi A, Kiessling R, Parmiani G. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res 2001; 61: 222–7. [PubMed] [Google Scholar]
  • 14. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 2001; 50: 515–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Yokota S, Kitahara M, Nagata K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon. Cancer Res 2000; 60: 2942–8. [PubMed] [Google Scholar]
  • 16. Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N, Shibuya K, Hiraoka M. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo . Clin Cancer Res 2001; 7: 215–9. [PubMed] [Google Scholar]
  • 17. Shibuya K, Kawasaki S, Kuroda M, Asaumi J, Kanazawa S, Hiraki Y. Effect of PKC inhibitors on suppression of thermotolerance development in tsAF8 cells. Int J Hyperthermia 2001; 17: 106–13. [DOI] [PubMed] [Google Scholar]
  • 18. Kitahara O, Furukawa Y, Tanaka T, Kihara C, Ono K, Yanagawa R, Marcelo EN, Takagi T, Nakamura Y, Tsunoda T. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser‐capture microdissection of tumor tissues. Cancer Res 2001; 61: 3544–9. [PubMed] [Google Scholar]
  • 19. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Borresen‐Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclass with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Park IK, He Y, Lin F, Laerum OD, Tian Q, Bumgarne R, Klug CA, Li K, Kuhr C, Doyle MJ, Xie T, Schummer M, Sun Y, Goldsmith A, Clarke MF, Weissman IL, Hood L, Li L. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood 2002; 99: 488–98. [DOI] [PubMed] [Google Scholar]
  • 21. Sesto A, Navarro M, Burslem F, Jorcano JL. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002; 99: 2965–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Tomida S, Hanai T, Honda H, Kobayashi T. Analysis of expression profile using fuzzy adaptive resonance theory. Bioinfomatics 2002; 18: 1073–83. [DOI] [PubMed] [Google Scholar]
  • 23. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome‐wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Herwig R, Poustka AJ, Muller C, Bull C, Lehrach H, O'Brien J. Large‐scale clustering of cDNA‐fingerprinting data. Genome Res 1999; 9: 1093–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR. Interpreting patterns of gene expression with self‐organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96: 2907–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT. Discovery of CGS 27023A, a non‐peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem 1997; 40: 2525–32. [DOI] [PubMed] [Google Scholar]
  • 27. Shaulian E, Karin M. AP‐1 in cell proliferation and survival. Oncogene 2001; 20: 2390–400. [DOI] [PubMed] [Google Scholar]
  • 28. O'Brien ML, Cunningham ML, Spear BT, Glauert HP. Peroxisome proliferators do not active the transcription factors AP‐1, early growth response‐1, or heat shock factors 1 and 2 in rats or hamsters. Toxicol Sci 2002; 69: 139–48. [DOI] [PubMed] [Google Scholar]
  • 29. Guo YL, Chang HC, Tsai JH, Huang JC, Li C, Young KC, Wu LW, Lai MD, Liu HS, Huang W. Two UVC‐induced stress response pathways in HeLa cells identified by cDNA microarray. Environ Mol Mutagen 2002; 40: 122–8. [DOI] [PubMed] [Google Scholar]
  • 30. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR‐1. Cancer Gene Ther 1998; 5: 3–28. [PubMed] [Google Scholar]
  • 31. Chuang YY, Chen Y, Gadisetti C, Chandramouli VR, Cook JA, Coffin D, Tsai MH, Degraff W, Yan H, Zhao S, Russo A, Liu ET, Mitchell JB. Gene expression after treatment with hydrogen peroxide, menadione, or t‐butyl hy‐droperoxide in breast cancer cells. Cancer Res 2002; 62: 6246–54. [PubMed] [Google Scholar]
  • 32. Werner RM, Jiang YL, Gordley RG, Jagadeesh GJ, Ladner JE, Tordova M, Gilliland GL, Stivers JT. Stressing‐out DNA; the contribution of serine‐phosphodiester interactions in catalysis by uracil DNA glycosylase. Biochemistry 2000; 39: 12585–94. [DOI] [PubMed] [Google Scholar]
  • 33. Buckbinder L, Velasco‐Miguel S, Chen Y, Xu N, Talbott R, Gelbert L, Gao J, Seizinger BR, Gutkind JS, Kley N. The p53 tumor suppressor targets a novel regulator of G protein signaling. Proc Natl Acad Sci USA 1997; 94: 7868–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Fiscella M, Zhang HL, Fan S, Sakaguchi K, Shen S, Mercer WE, Woude V, O'Connor PM, Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53‐dependent manner. Proc NatlAcadSci USA 1997; 94: 6048–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000; 19: 6642–50. [DOI] [PubMed] [Google Scholar]
  • 36. Hoekstra R, Eskens FA, Verwij J. Matrix metalloproteinase inhibitors: current developments and future perspectives. Oncologist 2001; 6: 415–27. [DOI] [PubMed] [Google Scholar]
  • 37. Kregel KC. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 2002; 92: 2177–86. [DOI] [PubMed] [Google Scholar]
  • 38. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 30: 21491–4. [DOI] [PubMed] [Google Scholar]
  • 39. Reuben PM, Brogley MA, Sun Y, Cheung HS. Molecular mechanisms of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium‐dependent protein kinase C alpha. J Biol Chem 2002; 277: 15190–8. [DOI] [PubMed] [Google Scholar]
  • 40. Reunanen N, Li SP, Ahonen M, Foschi M, Han J, Kahari VM. Activation of p38 alpha MAPK enhances collagenase‐1 (matrix metalloproteinase (MMP)‐1) and stromelysin‐1 (MMP‐3) expression by mRNA stabilization. J Biol Chem 2002; 277: 32360–8. [DOI] [PubMed] [Google Scholar]
  • 41. Matsuzawa K, Fukuyama K, Dirks PB, Hubbard S, Murakami M, Becker LE, Rutka JT. Expression of stromelysin 1 in human astrocytoma cell lines. J Neurooncol 1996; 30: 181–8. [DOI] [PubMed] [Google Scholar]
  • 42. Vance BA, Kowalski CG, Brinckerhoff CE. Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin. J Cell Biol 1989; 108: 2037–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Sato T, Sawaji Y, Matsui N, Sato H, Seiki M, Mori Y, Ito A. Heat shock suppresses membrane type 1‐matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT‐1080 cells and thereby inhibits cellular invasion. Biochem Biophys Res Commun 1999; 265: 189–93. [DOI] [PubMed] [Google Scholar]
  • 44. Reinermer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W. Structural implications for the role of the N terminus in the ‘superactivation’ of collagenases. A crystallographic study. FEBS Lett 1994; 338: 227–33. [DOI] [PubMed] [Google Scholar]
  • 45. Crabbe T, Willenbrock F, Eaton D, Hynds P, Carne AF, Murphy G, Docherty AJ. Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinases. Biochemistry 1992; 31: 8500–7. [DOI] [PubMed] [Google Scholar]
  • 46. Levitt NC, Eskens FALM, O'Byrne KJ, Propper DJ, Denis LJ, Owen SJ, Choi L, Foekens JA, Wilner S, Wood JM, Nakajima M, Talbot DC, Steward WP, Harris AL, Verweij J. Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. Clin Cancer Res 2001; 7: 1912–1922. [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES